Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial
| Title: | Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial |
|---|---|
| Authors: | Paz-Ares, Luis, Goto, Yasushi, Wan-Teck Lim, Darren, Halmos, Balazs, Chul Cho, Byoung, Cobo, Manuel, Luis González Larriba, José, Zhou, Caicun, Demedts, Ingel, Atmaca, Akin, Baka, Sofia, Mookerjee, Bijoyesh, Portella, Socorro, Zhu, Zewen, Wu, Jincheng, Demanse, David, Dharan, Bharani, Reck, Martin |
| Source: | In Lung Cancer March 2024 189 |
| Database: | ScienceDirect |
Be the first to leave a comment!